{
  "ticker": "RPTX",
  "company_name": "Repare Therapeutics Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05147350",
      "title": "Study of RP-6306 With FOLFIRI in Advanced Solid Tumors",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Advanced Solid Tumor",
      "start_date": "2022-08-09",
      "completion_date": "2025-02-12",
      "enrollment": 0,
      "sponsor": "Debiopharm International SA"
    },
    {
      "nct_id": "NCT06560632",
      "title": "Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Advanced Solid Tumor",
      "start_date": "2024-09-17",
      "completion_date": "2025-10-28",
      "enrollment": 0,
      "sponsor": "Repare Therapeutics"
    },
    {
      "nct_id": "NCT05147272",
      "title": "Study of RP-6306 With Gemcitabine in Advanced Solid Tumors",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Adult Solid Tumor",
      "start_date": "2021-12-16",
      "completion_date": "2024-08-28",
      "enrollment": 0,
      "sponsor": "Debiopharm International SA"
    },
    {
      "nct_id": "NCT05405309",
      "title": "RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Chronic Lymphocytic Leukemia",
      "start_date": "2022-09-23",
      "completion_date": "2025-01-10",
      "enrollment": 0,
      "sponsor": "University of Utah"
    },
    {
      "nct_id": "NCT04497116",
      "title": "Study of RP-3500, Camonsertib, in Advanced Solid Tumors",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Solid Tumor",
      "start_date": "2020-07-22",
      "completion_date": "2025-06-13",
      "enrollment": 0,
      "sponsor": "Repare Therapeutics"
    },
    {
      "nct_id": "NCT04972110",
      "title": "Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Solid Tumor, Adult",
      "start_date": "2021-07-21",
      "completion_date": "2024-11-13",
      "enrollment": 0,
      "sponsor": "Repare Therapeutics"
    },
    {
      "nct_id": "NCT06232408",
      "title": "LIONS (PLK4 Inhibitor in Advanced Solid Tumors)",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Advanced Solid Tumor",
      "start_date": "2024-02-14",
      "completion_date": "2025-08-27",
      "enrollment": 0,
      "sponsor": "Repare Therapeutics"
    },
    {
      "nct_id": "NCT05566574",
      "title": "A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Solid Tumor, Metastatic Cancer",
      "start_date": "2022-09-30",
      "completion_date": "2026-09-30",
      "enrollment": 0,
      "sponsor": "Memorial Sloan Kettering Cancer Center"
    },
    {
      "nct_id": "NCT05605509",
      "title": "RP-6306 in Patients With Advanced Cancer",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Advanced Cancer",
      "start_date": "2023-05-24",
      "completion_date": "2026-03-31",
      "enrollment": 0,
      "sponsor": "Canadian Cancer Trials Group"
    }
  ],
  "summary": {
    "total_trials": 9,
    "by_phase": {
      "PHASE1": 4,
      "PHASE1, PHASE2": 4,
      "PHASE2": 1
    },
    "by_status": {
      "TERMINATED": 6,
      "COMPLETED": 1,
      "ACTIVE_NOT_RECRUITING": 2
    },
    "active_trials": 2,
    "completed_trials": 1,
    "conditions": [
      "Adult Solid Tumor",
      "Advanced Cancer",
      "Advanced Solid Tumor",
      "Advanced Solid Tumor, Adult",
      "Chronic Lymphocytic Leukemia",
      "Solid Tumor, Metastatic Cancer"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:36:13.871135",
    "search_query": "Repare Therapeutics Inc.",
    "url": "https://clinicaltrials.gov/search?term=Repare+Therapeutics+Inc."
  }
}